MetaADEDB 2.0 @ LMMD
rizatriptan
(JPRXYLQNJJVCMZ-UHFFFAOYSA-N)
Structure
SMILES
OC(=O)c1ccccc1.CN(CCc1c[nH]c2c1cc(cc2)Cn1cncn1)C
Molecular Formula:
C22H25N5O2
Molecular Weight:
391.466
Log P:
3.2966
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
2
TPSA:
87.04
CAS Number(s):
145202-66-0
Synonym(s)
1.
rizatriptan
2.
L 705,126
3.
L 705126
4.
L-705,126
5.
L-705126
6.
MK 0462
7.
MK 462
8.
MK-0462
9.
MK-462
10.
Maxalt
11.
N,N-dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1H-indole-3-yl)ethylamine
12.
rizatriptan benzoate
External Link(s)
MeSHC093622
PubChem Compound77997
ChEBI8875
CHEMBLCHEMBL1201032
KEGGdr:D00675
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 137
Canada Vigilance: 18
Canada Vigilance
OFFSIDES
US FAERS
2HeadacheFAERS: 49
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
3NauseaFAERS: 36
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
4No adverse eventFAERS: 30US FAERS
5Myocardial InfarctionFAERS: 25US FAERS
6Product substitution issueFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
7VomitingFAERS: 24
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
8Chest PainFAERS: 22
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
9Drug exposure during pregnancyFAERS: 20OFFSIDES
US FAERS
10Chest discomfortFAERS: 19US FAERS
11MalaiseFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
12Adverse eventFAERS: 15OFFSIDES
US FAERS
13DizzinessFAERS: 15
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
14PainFAERS: 14
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
15HypersensitivityFAERS: 13SIDER
US FAERS
16Drug effect incompleteFAERS: 12US FAERS
17Expired product administeredFAERS: 12US FAERS
18Cerebrovascular accidentFAERS: 10US FAERS
19Feeling abnormalFAERS: 10
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
20AnxietyFAERS: 9
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
21AstheniaFAERS: 9OFFSIDES
SIDER
US FAERS
22OverdoseFAERS: 8OFFSIDES
US FAERS
23Product solubility abnormalFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
24Wrong technique in drug usage processFAERS: 8US FAERS
25Wrong technique in product usage processFAERS: 8US FAERS
26Acute myocardial infarctionFAERS: 7OFFSIDES
US FAERS
27DisabilityFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
28Intentional drug misuseFAERS: 7OFFSIDES
US FAERS
29MyalgiaFAERS: 7SIDER
US FAERS
30Prescribed overdoseFAERS: 7OFFSIDES
US FAERS
31Product physical issueFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
32Product taste abnormalFAERS: 7US FAERS
33SomnolenceFAERS: 7SIDER
US FAERS
34Drug dose omissionFAERS: 6US FAERS
35DysgeusiaFAERS: 6SIDER
US FAERS
36FatigueFAERS: 6
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
37HypotensionFAERS: 6US FAERS
38Medication ErrorFAERS: 6US FAERS
39PalpitationsFAERS: 6SIDER
US FAERS
40Product quality issueFAERS: 6US FAERS
41TachycardiaFAERS: 6SIDER
US FAERS
42TremorFAERS: 6SIDER
US FAERS
43Abdominal PainFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
44Abdominal discomfortFAERS: 5OFFSIDES
US FAERS
45DisorientationFAERS: 5SIDER
US FAERS
46HepatitisFAERS: 5US FAERS
47Intentional product misuseFAERS: 5US FAERS
48Lip swellingFAERS: 5US FAERS
49Maternal exposure during pregnancyFAERS: 5US FAERS
50Pharmaceutical product complaintFAERS: 5OFFSIDES
US FAERS
51TinnitusFAERS: 5OFFSIDES
US FAERS
52Ventricular FibrillationFAERS: 5OFFSIDES
US FAERS
53AgitationFAERS: 4US FAERS
54Cerebral vasoconstrictionFAERS: 4OFFSIDES
US FAERS
55ChillsFAERS: 4US FAERS
56DeafnessFAERS: 4OFFSIDES
US FAERS
57Depressed Level of ConsciousnessFAERS: 4OFFSIDES
US FAERS
58DiscomfortFAERS: 4SIDER
US FAERS
59EczemaFAERS: 4US FAERS
60HemiparesisFAERS: 4US FAERS
61Mental status changesFAERS: 4OFFSIDES
US FAERS
62Muscle RigidityFAERS: 4US FAERS
63Neck PainFAERS: 4SIDER
US FAERS
64Product blister packaging issueFAERS: 4US FAERS
65Product use issueFAERS: 4US FAERS
66UrticariaFAERS: 4SIDER
US FAERS
67Vascular occlusionFAERS: 4US FAERS
68VasospasmFAERS: 4OFFSIDES
US FAERS
69AgeusiaFAERS: 3US FAERS
70AnosmiaFAERS: 3US FAERS
71AphasiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
72ArthralgiaFAERS: 3US FAERS
73Atrial FibrillationFAERS: 3US FAERS
74Blood creatine phosphokinase increasedFAERS: 3US FAERS
75BradycardiaFAERS: 3SIDER
US FAERS
76Drug administration errorFAERS: 3OFFSIDES
US FAERS
77Drug effect delayedFAERS: 3US FAERS
78DysarthriaFAERS: 3US FAERS
79EpilepsyFAERS: 3US FAERS
80ErythemaFAERS: 3US FAERS
81Expired drug administeredFAERS: 3US FAERS
82Facial PainFAERS: 3SIDER
US FAERS
83Inappropriate schedule of drug administrationFAERS: 3OFFSIDES
US FAERS
84LethargyFAERS: 3OFFSIDES
US FAERS
85PregnancyFAERS: 3US FAERS
86Retinal DetachmentFAERS: 3US FAERS
87SinusitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
88ThrombosisFAERS: 3US FAERS
89Trisomy 21FAERS: 3OFFSIDES
US FAERS
90VasculitisFAERS: 3US FAERS
91Visual disturbanceFAERS: 3OFFSIDES
US FAERS
92Accidental overdoseFAERS: 2OFFSIDES
US FAERS
93AmnesiaFAERS: 2OFFSIDES
US FAERS
94Anaphylactic shockFAERS: 2SIDER
US FAERS
95AngioedemaFAERS: 2SIDER
US FAERS
96ApathyFAERS: 2OFFSIDES
US FAERS
97BlindnessFAERS: 2US FAERS
98Breast FeedingFAERS: 2US FAERS
99Cold sweatFAERS: 2US FAERS
100Contraindicated product administeredFAERS: 2US FAERS
101CystitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
102EosinophiliaFAERS: 2US FAERS
103ExophthalmosFAERS: 2US FAERS
104Extra dose administeredFAERS: 2US FAERS
105FlatulenceFAERS: 2US FAERS
106Hypertensive crisisFAERS: 2US FAERS
107HyperthyroidismFAERS: 2US FAERS
108Impaired driving abilityFAERS: 2US FAERS
109Incorrect dose administeredFAERS: 2US FAERS
110Incorrect route of drug administrationFAERS: 2US FAERS
111Intentional product use issueFAERS: 2US FAERS
112Lower respiratory tract infectionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
113Medication overuse headacheFAERS: 2US FAERS
114Memory impairmentFAERS: 2US FAERS
115Multiple SclerosisFAERS: 2OFFSIDES
US FAERS
116Musculoskeletal stiffnessFAERS: 2OFFSIDES
SIDER
US FAERS
117MyopathyFAERS: 2US FAERS
118NeuropathyFAERS: 2US FAERS
119Pain of skinFAERS: 2US FAERS
120PetechiaeFAERS: 2US FAERS
121Pharmaceutical product counterfeitFAERS: 2OFFSIDES
US FAERS
122Poor quality drug administeredFAERS: 2US FAERS
123Product formulation issueFAERS: 2US FAERS
124Product packaging issueFAERS: 2US FAERS
125Product use in unapproved indicationFAERS: 2US FAERS
126PruritusFAERS: 2SIDER
US FAERS
127Respiratory arrestFAERS: 2US FAERS
128ScreamingFAERS: 2OFFSIDES
US FAERS
129SneezingFAERS: 2US FAERS
130Sudden deathFAERS: 2US FAERS
131Therapy cessationFAERS: 2US FAERS
132ThrombocytopeniaFAERS: 2US FAERS
133Toxic Epidermal NecrolysisFAERS: 2SIDER
US FAERS
134VertigoFAERS: 2SIDER
US FAERS
135Visual ImpairmentFAERS: 2US FAERS
136Weight decreasedFAERS: 2US FAERS
137jaundiceFAERS: 2US FAERS
138treatment failureFAERS: 2US FAERS
139Aborted pregnancyFAERS: 1US FAERS
140Accidental exposure to product by childFAERS: 1US FAERS
141Accidental exposureFAERS: 1US FAERS
142Activities of daily living impairedFAERS: 1US FAERS
143Acute Coronary SyndromeFAERS: 1OFFSIDES
US FAERS
144AllodyniaFAERS: 1US FAERS
145AlopeciaFAERS: 1US FAERS
146Altered state of consciousnessFAERS: 1US FAERS
147AngerFAERS: 1OFFSIDES
US FAERS
148Angina PectorisFAERS: 1US FAERS
149Antidepressant therapyFAERS: 1US FAERS
150AuraFAERS: 1US FAERS
151BlepharospasmFAERS: 1OFFSIDES
US FAERS
152Blunted affectFAERS: 1US FAERS
153Burning sensationFAERS: 1OFFSIDES
US FAERS
154Carotid artery occlusionFAERS: 1US FAERS
155Cervicobrachial syndromeFAERS: 1OFFSIDES
US FAERS
156ChromaturiaFAERS: 1US FAERS
157Circumstance or information capable of leading to medication errorFAERS: 1OFFSIDES
US FAERS
158ColectomyFAERS: 1US FAERS
159Complications of maternal exposure to therapeutic drugsFAERS: 1US FAERS
160ConstipationFAERS: 1US FAERS
161Coronary artery insufficiencyFAERS: 1US FAERS
162Counterfeit drug administeredFAERS: 1US FAERS
163Cranial operationFAERS: 1US FAERS
164CryingFAERS: 1US FAERS
165DehydrationFAERS: 1US FAERS
166DeliriumFAERS: 1US FAERS
167Depressed moodFAERS: 1US FAERS
168DiplopiaFAERS: 1OFFSIDES
US FAERS
169Drug abuserFAERS: 1OFFSIDES
US FAERS
170Drug abuseFAERS: 1US FAERS
171Drug administered to patient of inappropriate ageFAERS: 1US FAERS
172Drug ineffective for unapproved indicationFAERS: 1US FAERS
173Drug prescribing errorFAERS: 1US FAERS
174Dry skinFAERS: 1US FAERS
175DyspepsiaFAERS: 1SIDER
US FAERS
176Emergency CareFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
177EncephalitisFAERS: 1OFFSIDES
US FAERS
178Erythema MultiformeFAERS: 1US FAERS
179Euphoric moodFAERS: 1OFFSIDES
US FAERS
180Eye irritationFAERS: 1US FAERS
181Feeling jitteryFAERS: 1US FAERS
182FlushingFAERS: 1SIDER
US FAERS
183General symptomFAERS: 1OFFSIDES
US FAERS
184Gluten sensitivityFAERS: 1US FAERS
185Guillain-Barre SyndromeFAERS: 1US FAERS
186HELLP SyndromeFAERS: 1US FAERS
187Hallucinations, mixedFAERS: 1US FAERS
188Head discomfortFAERS: 1US FAERS
189HyperkinesiaFAERS: 1US FAERS
190HyperventilationFAERS: 1US FAERS
191Hypothenar hammer syndromeFAERS: 1US FAERS
192Impaired quality of lifeFAERS: 1US FAERS
193Impaired work abilityFAERS: 1US FAERS
194IncoherentFAERS: 1US FAERS
195InfectionFAERS: 1US FAERS
196LabyrinthitisFAERS: 1US FAERS
197Lactose IntoleranceFAERS: 1US FAERS
198MenorrhagiaFAERS: 1US FAERS
199MetrorrhagiaFAERS: 1US FAERS
200Milk AllergyFAERS: 1US FAERS
201Muscle tightnessFAERS: 1OFFSIDES
US FAERS
202MutismFAERS: 1US FAERS
203MyocarditisFAERS: 1US FAERS
204MyositisFAERS: 1US FAERS
205No adverse effectFAERS: 1OFFSIDES
US FAERS
206No adverse reactionFAERS: 1US FAERS
207Oral mucosal eruptionFAERS: 1US FAERS
208PallorFAERS: 1OFFSIDES
US FAERS
209Peripheral swellingFAERS: 1US FAERS
210Personality ChangeFAERS: 1OFFSIDES
US FAERS
211Pharyngeal swellingFAERS: 1US FAERS
212PhotophobiaFAERS: 1US FAERS
213PoisoningFAERS: 1US FAERS
214PolydactylyFAERS: 1US FAERS
215Poor quality product administeredFAERS: 1US FAERS
216Poor quality sleepFAERS: 1US FAERS
217Post procedural complicationFAERS: 1OFFSIDES
US FAERS
218Prescription drug used without a prescriptionFAERS: 1US FAERS
219Procedural complicationFAERS: 1OFFSIDES
US FAERS
220Product availability issueFAERS: 1US FAERS
221Product dose omissionFAERS: 1US FAERS
222Product outer packaging issueFAERS: 1US FAERS
223Product packaging quantity issueFAERS: 1US FAERS
224Product storage errorFAERS: 1US FAERS
225Product supply issueFAERS: 1US FAERS
226PsoriasisFAERS: 1US FAERS
227Psychomotor AgitationFAERS: 1US FAERS
228Rash erythematousFAERS: 1US FAERS
229Reaction to food additiveFAERS: 1US FAERS
230Respiratory distressFAERS: 1US FAERS
231RestlessnessFAERS: 1US FAERS
232RetchingFAERS: 1US FAERS
233Retinal Artery OcclusionFAERS: 1US FAERS
234Reversible cerebral vasoconstriction syndromeFAERS: 1US FAERS
235Serotonin SyndromeFAERS: 1SIDER
US FAERS
236ShockFAERS: 1SIDER
US FAERS
237Skin lesionFAERS: 1US FAERS
238SoporFAERS: 1US FAERS
239StillbirthFAERS: 1US FAERS
240StressFAERS: 1US FAERS
241StuporFAERS: 1US FAERS
242Suicide attemptFAERS: 1US FAERS
243Supraventricular tachycardiaFAERS: 1OFFSIDES
US FAERS
244Tablet physical issueFAERS: 1US FAERS
245Temperature intoleranceFAERS: 1US FAERS
246Tension HeadacheFAERS: 1OFFSIDES
US FAERS
247Therapeutic product effect incompleteFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
248Throat cancerFAERS: 1US FAERS
249Throat irritationFAERS: 1US FAERS
250Tongue pruritusFAERS: 1US FAERS
251Type II hypersensitivityFAERS: 1US FAERS
252Unevaluable eventFAERS: 1OFFSIDES
US FAERS
253Urine output increasedFAERS: 1US FAERS
254Violence-related symptomFAERS: 1US FAERS
255nervous system disorderFAERS: 1US FAERS
256Abdominal tendernessOFFSIDES
257AbuseOFFSIDES
258Acid refluxOFFSIDES
259ActinomycosisOFFSIDES
260Acute prerenal failureOFFSIDES
261Acute respiratory failureOFFSIDES
262AdenocarcinomaOFFSIDES
263AgraphiaOFFSIDES
264Alcohol withdrawal syndromeOFFSIDES
265Altered bowel functionOFFSIDES
266AmphetaminesOFFSIDES
267Anaphylactoid ReactionSIDER
268AnhidrosisOFFSIDES
269Ankle FractureOFFSIDES
270Anoxic EncephalopathyOFFSIDES
271Anticholinergic SyndromeOFFSIDES
272Antidepressant drug level increasedOFFSIDES
273AppendicitisOFFSIDES
274ArthritisOFFSIDES
275ArthropathyOFFSIDES
276ArthroscopyOFFSIDES
277AsthmaOFFSIDES
278AtaxiaSIDER
279Autoimmune inner ear diseaseOFFSIDES
280AutomatismOFFSIDES
281BelligerenceOFFSIDES
282Bipolar DisorderOFFSIDES
283Bipolar I disorderOFFSIDES
284Bladder prolapseOFFSIDES
285BlepharoptosisOFFSIDES
286Blood GlucoseOFFSIDES
287Blood alkaline phosphatase increasedOFFSIDES
288Blood cholesterolOFFSIDES
289Blood homocysteine decreasedOFFSIDES
290Blood pH decreasedOFFSIDES
291Blood potassium decreasedOFFSIDES
292Blood prolactin increasedOFFSIDES
293Blurred visionOFFSIDES
294Bone density decreasedOFFSIDES
295Brain HypoxiaOFFSIDES
296Breast CystOFFSIDES
297BronchitisOFFSIDES
298BrucellosisOFFSIDES
299Bulbar palsyOFFSIDES
300BursitisOFFSIDES
301Calcific deposits removalOFFSIDES
302Catheter bacteraemiaOFFSIDES
303Central nervous system lesionOFFSIDES
304Cerebral artery occlusionOFFSIDES
305Cervical dysplasiaOFFSIDES
306Choking sensationOFFSIDES
307Chronic left ventricular failureOFFSIDES
308Chronic sinusitisOFFSIDES
309ColitisOFFSIDES
310Colonic StenosisOFFSIDES
311Completed SuicideOFFSIDES
312Complication of deliveryOFFSIDES
313ConfabulationOFFSIDES
314Culture positiveOFFSIDES
315CystOFFSIDES
316DebridementOFFSIDES
317DemyelinationOFFSIDES
318Dental abscessOFFSIDES
319Dental cariesOFFSIDES
320Dental discomfortOFFSIDES
321DependenceOFFSIDES
322DermatitisSIDER
323Device breakageOFFSIDES
324DiarrheaOFFSIDES
325DiverticulosisOFFSIDES
326DrowsinessOFFSIDES
327Drug addictOFFSIDES
328Drug screen positiveOFFSIDES
329Drug withdrawal headacheOFFSIDES
330Duodenal UlcerOFFSIDES
331DuodenitisOFFSIDES
332DyspareuniaOFFSIDES
333DysphemiaOFFSIDES
334Dyspnoea exacerbatedOFFSIDES
335Dysthymic DisorderOFFSIDES
336DystoniaOFFSIDES
337DysuriaOFFSIDES
338Economic problemOFFSIDES
339Emotional distressOFFSIDES
340Endodontic procedureOFFSIDES
341EpicondylitisOFFSIDES
342EscharOFFSIDES
343Eye inflammationOFFSIDES
344Eye painOFFSIDES
345Facial NeuralgiaOFFSIDES
346Factor VIII inhibitionOFFSIDES
347Failure of implantOFFSIDES
348Fatty LiverOFFSIDES
349Feeding disorder neonatalOFFSIDES
350FibromyalgiaOFFSIDES
351Flank PainOFFSIDES
352Fluid overloadOFFSIDES
353FolliculitisOFFSIDES
354Food AllergyOFFSIDES
355FormicationOFFSIDES
356GalactorrheaOFFSIDES
357Gallop rhythm presentOFFSIDES
358Gastric BypassOFFSIDES
359GastroenteritisOFFSIDES
360Gastrointestinal PainSIDER
361Gastrointestinal inflammationOFFSIDES
362Genital HerpesOFFSIDES
363Genital rashOFFSIDES
364Gestational DiabetesOFFSIDES
365Gingival blisterOFFSIDES
366GlioblastomaOFFSIDES
367Heart-lung transplant rejectionOFFSIDES
368HostilityOFFSIDES
369HydronephrosisOFFSIDES
370HypophonesisOFFSIDES
371HypospadiasOFFSIDES
372Incorrect product dosage form administeredCanada Vigilance: 1Canada Vigilance
373Infusion site mobility decreasedOFFSIDES
374Injection site urticariaOFFSIDES
375Intention tremorOFFSIDES
376Intervertebral Disc DegenerationOFFSIDES
377Intestinal PerforationOFFSIDES
378Joint InstabilityOFFSIDES
379Joint Range of Motion DecreasedOFFSIDES
380Joint sprainOFFSIDES
381Leukopenia neonatalOFFSIDES
382Life expectancy shortenedOFFSIDES
383Ligament ruptureOFFSIDES
384Lipoma of breastOFFSIDES
385Low turnover osteopathyOFFSIDES
386Lumbar radiculopathyOFFSIDES
387Mass excisionOFFSIDES
388Mechanical urticariaOFFSIDES
389Meniscus removalOFFSIDES
390Mental impairmentOFFSIDES
391MetatarsalgiaOFFSIDES
392MicroalbuminuriaOFFSIDES
393Migraine with AuraOFFSIDES
394MonoplegiaOFFSIDES
395Multiple drug overdoseOFFSIDES
396Multiple sclerosis relapseOFFSIDES
397Muscle FatigueOFFSIDES
398Muscle WeaknessOFFSIDES
399Musculoskeletal discomfortSIDER
400NervousnessSIDER
401NeuralgiaOFFSIDES
402OnychalgiaOFFSIDES
403OpisthotonusOFFSIDES
404Optic AtrophyOFFSIDES
405Oropharyngeal blisteringOFFSIDES
406Oropharyngeal discomfortCanada Vigilance: 1Canada Vigilance
407OsteolysisOFFSIDES
408OsteomaOFFSIDES
409OsteosclerosisOFFSIDES
410OtosclerosisOFFSIDES
411PCO2 increasedOFFSIDES
412Panic DisorderOFFSIDES
413ParanoiaOFFSIDES
414Physical assaultOFFSIDES
415Physical disabilityOFFSIDES
416PneumoniaCanada Vigilance: 1Canada Vigilance
417PneumoperitoneumOFFSIDES
418Polysubstance abuseOFFSIDES
419Post-traumatic painOFFSIDES
420Postoperative abscessOFFSIDES
421Pregnancy on oral contraceptiveOFFSIDES
422Primary sequestrumOFFSIDES
423Protein C increasedOFFSIDES
424Protein S decreasedOFFSIDES
425PseudoporphyriaOFFSIDES
426PterygiumOFFSIDES
427Pulmonary congestionOFFSIDES
428Pulmonary thrombosisOFFSIDES
429Purulent dischargeOFFSIDES
430Radicular painOFFSIDES
431Rectal ProlapseOFFSIDES
432RectoceleOFFSIDES
433Respiratory tract congestionOFFSIDES
434Retinal vascular occlusionOFFSIDES
435RetrocollisOFFSIDES
436RhinitisOFFSIDES
437Risus sardonicusOFFSIDES
438Salpingo-oophorectomyOFFSIDES
439Schizoaffective DisorderOFFSIDES
440Serum SicknessOFFSIDES
441Shoulder PainOFFSIDES
442SomnambulismCanada Vigilance: 1Canada Vigilance
443SpondylolisthesisOFFSIDES
444StaringOFFSIDES
445Stenotrophomonas infectionOFFSIDES
446StiffnessSIDER
447Stomatocytes presentOFFSIDES
448Superficial ThrombophlebitisOFFSIDES
449SweatingSIDER
450SyncopeSIDER
451Synovial CystOFFSIDES
452SynovitisOFFSIDES
453Tarsal Tunnel SyndromeOFFSIDES
454TendinitisOFFSIDES
455TenosynovitisOFFSIDES
456TensionSIDER
457Therapeutic response unexpectedOFFSIDES
458ThirstSIDER
459Tooth ExtractionOFFSIDES
460UlcerOFFSIDES
461Ventricular arrhythmiaCanada Vigilance: 2Canada Vigilance
462Viral upper respiratory tract infectionOFFSIDES
463Vitamin A DeficiencyOFFSIDES
464Vulvovaginal pruritusOFFSIDES
465Weight GainOFFSIDES
466WheezingSIDER
467Wound DebridementOFFSIDES
468Wound InfectionOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.